A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer
by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of
Updated on: January 08,2024
6

A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer
by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of
Updated on:January 08,2024
6
